Daily Stock Analysis, ISR, IsoRay Inc, priceseries

IsoRay Inc. Daily Stock Analysis
Stock Information
Open
0.41
Close
0.41
High
0.42
Low
0.41
Previous Close
0.41
Daily Price Gain
-0.00
YTD High
0.49
YTD High Date
May 22, 2019
YTD Low
0.29
YTD Low Date
Jan 2, 2019
YTD Price Change
0.08
YTD Gain
25.58%
52 Week High
0.67
52 Week High Date
Jul 30, 2018
52 Week Low
0.27
52 Week Low Date
Dec 28, 2018
52 Week Price Change
-0.20
52 Week Gain
-33.11%
Company Information
Stock Symbol
ISR
Exchange
NYSE MKT
Company URL
http://www.isoray.com
Company Phone
(509) 375-1202
CEO
Thomas C. LaVoy
Headquarters
Washington
Business Address
350 HILLS STREET,, SUITE 106, RICHLAND, WA 99354
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0000728387
About

IsoRay, Inc. produces therapeutic radioactive isotopes. It provides applications include prostate cancer; ocular melanoma; head, neck and lung tumors; breast cancer; liver cancer; brain cancer; colorectal cancer; gynecological cancer; esophageal cancer; and pancreatic cancer. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

Description

IsoRay, Inc. develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are performed. The company was formerly known as Century Park Pictures Corporation and changed its name to IsoRay, Inc. in 2005. IsoRay, Inc. was founded in 1983 and is headquartered in Richland, Washington.